The firm will use OmniComm’s TrialMaster phase I application to collect data at phase I in-patient units. Laboratory data will be imported into the application in an attempt to allow normal range verification, query laboratory data and reduce or eliminate the need to combine multiple streams of data in order to complete analysis.